Medtronic, Nile Therapeutics to work on drug-device combo

02/28/2011 | American City Business Journals

Medtronic has agreed to partner with Nile Therapeutics to develop a peptide drug, called cenderitide, for heart failure and renal disease that can be delivered by its diabetes pump system. Under the agreement, Nile will focus on conducting a first-stage trial of the peptide, and Medtronic will provide financing and share its knowledge in developing drug-device combination products.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN